+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Travelers Vaccines Market - Global Forecast 2026-2032- Product Image
Travelers Vaccines Market - Global Forecast 2026-2032- Product Image
Sale

Travelers Vaccines Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6277873
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Travelers Vaccines: Executive Overview

Travelers vaccines support prevention of infectious diseases associated with international movement, including destination-specific, food- and water-borne, vector-borne, and routine immunization risks. Demand is shaped by travel volumes, destination profiles, public-health guidance, clinical access, traveler awareness, and requirements for entry or employment. The market spans pre-travel consultations, vaccine administration, documentation, and complementary prevention advice.

How Travel Patterns and Health Policies Are Reshaping Prevention

Travel health is evolving as mobility becomes more diverse, including tourism, business travel, migration, education, humanitarian work, and visiting friends and relatives. Providers increasingly need to assess itinerary, duration, season, accommodation, activities, medical history, and prior immunization rather than apply a one-size-fits-all schedule. Regulatory changes, outbreaks, border requirements, and stronger emphasis on routine immunization are also moving travel vaccination toward integrated preventive care.

Artificial Intelligence’s Cumulative Role in Travel Vaccination

Artificial intelligence can help clinicians organize destination-specific guidance, identify missing immunization records, support risk triage, and generate personalized consultation prompts from itinerary data. It may also improve appointment planning, stock management, multilingual education, and post-travel symptom routing. Safe adoption requires authoritative data sources, clinical oversight, transparent reasoning, protection of sensitive health information, and safeguards against outdated recommendations or inappropriate automated advice.

Regional Insights Across the Global Travel Health Landscape

North America combines established travel-medicine services with varied access across urban and rural settings, while Latin America reflects diverse destination risks, uneven preventive-care capacity, and substantial domestic and international mobility. Europe benefits from extensive cross-border travel and mature public-health infrastructure, although guidance and reimbursement can differ by country. The Middle East remains influenced by pilgrimage, labor mobility, and major international transport links. Africa presents wide variation in disease exposure, healthcare access, and traveler consultation availability. Asia-Pacific encompasses high-volume regional travel, dense population centers, island destinations, and differing national immunization policies, making itinerary-specific assessment especially important.

Group-Level Dynamics Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN’s closely connected travel corridors create demand for coordinated destination guidance and accessible pre-travel services across differing health systems. BRICS members span major outbound and inbound travel markets with varied regulatory frameworks, disease environments, and public-health capacities. The European Union benefits from cross-border coordination but retains national differences in clinical practice and documentation. G7 countries generally have strong travel-health infrastructure, while GCC states are shaped by international workforce mobility, pilgrimage, and centralized health initiatives. NATO-related mobility increases the importance of occupational readiness, standardized records, and rapid vaccination access for personnel and affiliated travelers.

Country-Level Priorities from Australia to the United States

Australia emphasizes tropical and regional travel risks alongside strong preventive-care systems. Brazil and Mexico require itinerary-sensitive counseling because exposure profiles vary substantially by region. Canada and the United States have broad outbound travel networks and diverse access models for travel clinics. China, India, Japan, and South Korea combine large domestic and international travel populations with distinct regulatory and clinical pathways. France, Germany, Italy, Spain, and the United Kingdom operate within highly mobile European travel networks while maintaining country-specific recommendations, reimbursement practices, and documentation processes. Russia’s travel-health needs reflect varied climates, destinations, and access considerations. Across all listed countries, providers benefit from integrating routine immunization review with destination-specific counseling.

Actions for Leaders to Improve Travel Vaccine Access and Readiness

Industry leaders should build destination-risk workflows that capture itinerary, timing, traveler characteristics, and medical history, while keeping recommendations linked to current public-health guidance. They should strengthen clinician training, appointment availability, cold-chain reliability, stock rotation, and interoperable immunization records. Clear multilingual communication can improve informed consent and adherence, especially for travelers visiting friends and relatives or traveling on short notice. Organizations should also measure consultation timeliness, missed opportunities for routine vaccination, adverse-event reporting, and equity of access. AI-enabled tools should remain decision support, with governance, validation, privacy controls, and human accountability embedded from deployment onward.

Research Methodology for the Travelers Vaccines Assessment

This executive summary uses a structured qualitative assessment of the travelers-vaccine landscape. The approach considers disease risk by destination, travel purpose and behavior, immunization policy, healthcare delivery, regulatory requirements, clinical workflows, technology adoption, and access conditions. Findings are organized across the specified regions, country groupings, and countries, with emphasis on verifiable public-health principles and observable system dynamics. No market estimates, market shares, forecasts, or company-level claims are included.

Conclusion: Building More Responsive Travel Vaccination Systems

Travel vaccination is increasingly part of a broader travel-health model that combines routine immunization, destination assessment, documentation, education, and post-travel support. Regional and country differences make flexible, evidence-based workflows essential, while cross-border mobility increases the value of coordinated guidance and interoperable records. Leaders that pair strong clinical governance with convenient access, reliable supply processes, and carefully controlled digital tools will be better positioned to protect travelers and strengthen prevention across changing travel patterns.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Travelers Vaccines Market, by Vaccine Type
7.1. Introduction
7.2. Japanese Encephalitis
7.3. Influenza
7.4. Hepatitis B
7.5. Hepatitis A
7.6. Cholera
8. Travelers Vaccines Market, by Traveler Type
8.1. Introduction
8.2. Visiting Friends And Relatives
8.3. Tourists
8.4. Students
8.5. Pilgrims
8.6. Expat Longer Term
8.7. Business Travelers
8.8. Backpackers Adventure Travelers
9. Travelers Vaccines Market, by Distribution Channel
9.1. Introduction
9.2. Outreach Programs
9.3. Online Telehealth
9.4. Hospitals
9.5. Corporate Occupational Clinics
10. Travelers Vaccines Market, by Product Form
10.1. Introduction
10.2. Single Antigen
10.3. Prefilled Syringe
10.4. Oral Formulation
10.5. Multi Dose Vial
10.6. Combination Vaccines
11. Travelers Vaccines Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Travelers Vaccines Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Travelers Vaccines Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. AJ Vaccines A/S
15.3. AstraZeneca PLC
15.4. Bavarian Nordic A/S
15.5. Bharat Biotech International Limited
15.6. Biological E. Limited
15.7. BioNTech SE
15.8. Chiron Behring Vaccines Pvt. Ltd.
15.9. CSL Limited
15.10. Dynavax Technologies
15.11. Emergent BioSolutions Inc.
15.12. GC Biopharma Corp.
15.13. GlaxoSmithKline plc
15.14. GreenSignal Bio Pharma Pvt Limited
15.15. Haffkine Bio-Pharmaceutical Corporation Ltd.
15.16. Indian Immunologicals Ltd.
15.17. Japan BCG Laboratory
15.18. Johnson & Johnson
15.19. Merck & Co., Inc.
15.20. Moderna, Inc.
15.21. Novavax, Inc.
15.22. Panacea Biotec Limited
15.23. Pfizer Inc.
15.24. Sanofi SA
15.25. Serum Institute of India Pvt. Ltd.
15.26. Takeda Pharmaceutical Company Limited
15.27. Valneva SE
15.28. Xiamen Innovax Biotech Co. Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Travelers Vaccines Market, Years Considered for the Study
FIGURE 2. Global Travelers Vaccines Market, Research Design
FIGURE 3. Global Travelers Vaccines Market, Research Framework
FIGURE 4. Global Travelers Vaccines Market, Data Triangulation
FIGURE 5. Global Travelers Vaccines Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Travelers Vaccines Market Size, by Vaccine Type, 2025 vs 2032 (%)
FIGURE 7. Global Travelers Vaccines Market Size, by Vaccine Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Travelers Vaccines Market Size, by Traveler Type, 2025 vs 2032 (%)
FIGURE 9. Global Travelers Vaccines Market Size, by Traveler Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Travelers Vaccines Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Travelers Vaccines Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Travelers Vaccines Market Size, by Product Form, 2025 vs 2032 (%)
FIGURE 13. Global Travelers Vaccines Market Size, by Product Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Travelers Vaccines Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Travelers Vaccines Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Travelers Vaccines Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Travelers Vaccines Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Travelers Vaccines Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Travelers Vaccines Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Travelers Vaccines Market Segmentation & Coverage
TABLE 2. Global Travelers Vaccines Market Size, 2017-2032 (USD Million)
TABLE 3. Global Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 4. Global Japanese Encephalitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Japanese Encephalitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Japanese Encephalitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Influenza Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Influenza Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Influenza Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Hepatitis B Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Hepatitis B Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Hepatitis B Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Hepatitis A Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Hepatitis A Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Hepatitis A Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Cholera Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Cholera Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Cholera Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 20. Global Visiting Friends And Relatives Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Visiting Friends And Relatives Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Visiting Friends And Relatives Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Tourists Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Tourists Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Tourists Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Students Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Students Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Students Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Pilgrims Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Pilgrims Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Pilgrims Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Expat Longer Term Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Expat Longer Term Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Expat Longer Term Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Business Travelers Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Business Travelers Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Business Travelers Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Backpackers Adventure Travelers Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Backpackers Adventure Travelers Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Backpackers Adventure Travelers Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 42. Global Outreach Programs Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Outreach Programs Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Outreach Programs Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Online Telehealth Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Online Telehealth Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Online Telehealth Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Corporate Occupational Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Corporate Occupational Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Corporate Occupational Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 55. Global Single Antigen Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Single Antigen Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Single Antigen Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Prefilled Syringe Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Prefilled Syringe Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Prefilled Syringe Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Oral Formulation Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Oral Formulation Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Oral Formulation Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Multi Dose Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Multi Dose Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Multi Dose Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Combination Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Combination Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Combination Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Travelers Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Travelers Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 76. North America Travelers Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. North America Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 78. North America Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 79. North America Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 80. North America Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 81. Latin America Travelers Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Latin America Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 83. Latin America Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 84. Latin America Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 85. Latin America Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 86. Europe Travelers Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Europe Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 88. Europe Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 89. Europe Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. Europe Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 91. Middle East Travelers Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Middle East Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 93. Middle East Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 94. Middle East Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 95. Middle East Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 96. Africa Travelers Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Africa Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 98. Africa Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 99. Africa Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 100. Africa Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 101. Global Travelers Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. ASEAN Travelers Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. ASEAN Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 104. ASEAN Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 105. ASEAN Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. ASEAN Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 107. GCC Travelers Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. GCC Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 109. GCC Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 110. GCC Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 111. GCC Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 112. European Union Travelers Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. European Union Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 114. European Union Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 115. European Union Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 116. European Union Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 117. BRICS Travelers Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. BRICS Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 119. BRICS Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 120. BRICS Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 121. BRICS Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 122. G7 Travelers Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. G7 Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 124. G7 Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 125. G7 Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 126. G7 Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 127. NATO Travelers Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. NATO Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 129. NATO Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 130. NATO Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 131. NATO Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 132. Global Travelers Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. United States Travelers Vaccines Market Size, 2017-2032 (USD Million)
TABLE 134. United States Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 135. United States Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 136. United States Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 137. United States Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 138. Canada Travelers Vaccines Market Size, 2017-2032 (USD Million)
TABLE 139. Canada Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 140. Canada Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 141. Canada Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. Canada Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 143. Mexico Travelers Vaccines Market Size, 2017-2032 (USD Million)
TABLE 144. Mexico Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 145. Mexico Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 146. Mexico Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 147. Mexico Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 148. Brazil Travelers Vaccines Market Size, 2017-2032 (USD Million)
TABLE 149. Brazil Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 150. Brazil Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 151. Brazil Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. Brazil Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 153. United Kingdom Travelers Vaccines Market Size, 2017-2032 (USD Million)
TABLE 154. United Kingdom Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 155. United Kingdom Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 156. United Kingdom Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 157. United Kingdom Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 158. Germany Travelers Vaccines Market Size, 2017-2032 (USD Million)
TABLE 159. Germany Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 160. Germany Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 161. Germany Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. Germany Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 163. France Travelers Vaccines Market Size, 2017-2032 (USD Million)
TABLE 164. France Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 165. France Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 166. France Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 167. France Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 168. Russia Travelers Vaccines Market Size, 2017-2032 (USD Million)
TABLE 169. Russia Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 170. Russia Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 171. Russia Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. Russia Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 173. Italy Travelers Vaccines Market Size, 2017-2032 (USD Million)
TABLE 174. Italy Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 175. Italy Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 176. Italy Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 177. Italy Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 178. Spain Travelers Vaccines Market Size, 2017-2032 (USD Million)
TABLE 179. Spain Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 180. Spain Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 181. Spain Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. Spain Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 183. China Travelers Vaccines Market Size, 2017-2032 (USD Million)
TABLE 184. China Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 185. China Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 186. China Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 187. China Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 188. India Travelers Vaccines Market Size, 2017-2032 (USD Million)
TABLE 189. India Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 190. India Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 191. India Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 192. India Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 193. Japan Travelers Vaccines Market Size, 2017-2032 (USD Million)
TABLE 194. Japan Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 195. Japan Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 196. Japan Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 197. Japan Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 198. Australia Travelers Vaccines Market Size, 2017-2032 (USD Million)
TABLE 199. Australia Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 200. Australia Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 201. Australia Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 202. Australia Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 203. South Korea Travelers Vaccines Market Size, 2017-2032 (USD Million)
TABLE 204. South Korea Travelers Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 205. South Korea Travelers Vaccines Market Size, by Traveler Type, 2017-2032 (USD Million)
TABLE 206. South Korea Travelers Vaccines Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 207. South Korea Travelers Vaccines Market Size, by Product Form, 2017-2032 (USD Million)
TABLE 208. Global Travelers Vaccines Market Share, by Key Player, 2025
TABLE 209. Global Travelers Vaccines Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • AJ Vaccines A/S
  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • Bharat Biotech International Limited
  • Biological E. Limited
  • BioNTech SE
  • Chiron Behring Vaccines Pvt. Ltd.
  • CSL Limited
  • Dynavax Technologies
  • Emergent BioSolutions Inc.
  • GC Biopharma Corp.
  • GlaxoSmithKline plc
  • GreenSignal Bio Pharma Pvt Limited
  • Haffkine Bio-Pharmaceutical Corporation Ltd.
  • Indian Immunologicals Ltd.
  • Japan BCG Laboratory
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Novavax, Inc.
  • Panacea Biotec Limited
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Company Limited
  • Valneva SE
  • Xiamen Innovax Biotech Co. Ltd.

Related Topics

Related Reports

Travel Vaccines Market - Global Forecast 2026-2032 - Product Image

Travel Vaccines Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Meningococcal Vaccines Market - Global Forecast 2026-2032 - Product Image

Meningococcal Vaccines Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Human Rabies Vaccines Market - Global Forecast 2026-2032 - Product Image

Human Rabies Vaccines Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Oral Vaccine Market - Global Forecast 2026-2032 - Product Image

Oral Vaccine Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
23-Valent Pneumococcal Polysaccharide Vaccine Market - Global Forecast 2026-2032 - Product Image

23-Valent Pneumococcal Polysaccharide Vaccine Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.